ETRA — Electra Therapeutics, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 2088082 ·
Last close
$11.25
Market Cap
—
52W High
$15.50
52W Low
$11.00
ADV30
1,146,066
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 106,498,000 66,507,000 325,953,000
Dec 2025 — — — — 99,368,000 33,008,000 262,810,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-221,890,000
Inventory
—
Receivables
$264,000
ST Investments
$31,218,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -61,889,000 -61,975,000 99,368,000 129,694,000 -30,326,000 -60,484,000
Dec 2024 0 -26,317,000 -24,786,000 19,420,000 122,681,000 -103,261,000 -26,003,000

Peers — same industry

TickerNameMarket CapLastDaily %
AMGN AMGEN INC $227.88B $421.51 —
GILD GILEAD SCIENCES, INC. $184.82B $149.05 —
MRNA Moderna, Inc. $76.88B $192.57 —
ARGX ARGENX SE $59.63B $958.91 —
RVMD Revolution Medicines, Inc. $43.99B $205.26 —

News headlines (Yahoo Finance, 1h cache)

Oura Shows How Shaky the IPO Market Really Is
2026-09-30 12:23 · Yahoo
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering
2026-09-18 00:30 · Yahoo

Recent Insider Activity

FiledTradeInsiderTitleType PriceQtyValue
2026-09-23 17:29:42 2026-09-21 Orbimed Advisors LLC Dir, 10% P - Purchase 15 1333333 19999995